注:1、汇添富纳斯达克生物科技ETF发起式联接（QDII）人民币A、汇添富纳斯达克生物科技ETF发起 式联接（QDII）人民币C自2025年09月02日起限制大额申购、大额定期定额投资业务，限制金额为 50000人民币元，汇添富纳斯达克生物科技ETF发起式联接（QDII）美元现钞、汇添富纳斯达克生物科 技ETF发起式联接（QDII）美元现汇自2025年09月02日起限制大额申购、大额定期定额投资业务，限制 金额为7000美元，详见本公司于2025年09月02日发布的《关于汇添富纳斯达克生物科技交易型开放式指 数证券投资基金发起式联接基金（QDII）暂停大额申购、定期定额投资业务的公告》。 证券之星消息，11月4日汇添富基金管理股份有限公司发布《关于汇添富纳斯达克生物科技交易型开放 式指数证券投资基金发起式联接基金（QDII）调整大额申购、定期定额投资业务限制金额的公告》。 公告中提示，为保护基金份额持有人的利益，保障基金平稳运作，根据《汇添富纳斯达克生物科技交易 型开放式指数证券投资基金发起式联接基金（QDII）基金合同》的有关规定，自2025年11月5日起汇添 富纳斯达克生物科技交易型开放式指数证券投资基金 ...

证券之星消息，9月2日汇添富基金管理股份有限公司发布《关于汇添富纳斯达克生物科技交易型开放式 指数证券投资基金发起式联接基金（QDII）暂停大额申购、定期定额投资业务的公告》。公告中提 示，为保护基金份额持有人的利益，保障基金平稳运作，根据《汇添富纳斯达克生物科技交易型开放式 指数证券投资基金发起式联接基金（QDII）基金合同》的有关规定，自2025年9月2日起汇添富纳斯达 克生物科技交易型开放式指数证券投资基金发起式联接基金（QDII）暂停大额申购、定期定额投资业 务，下属分级基金调整明细如下： 注:1、自2025年09月02日起（含2025年09月02日），汇添富纳斯达克生物科技ETF发起式联接（QDII） 人民币A暂停大额申购、大额定期定额投资业务，单日单个基金账户单笔或多笔累计申购、定期定额投 资的金额不应超过50000人民币元（含50000人民币元）。当单日某基金账户单笔或多笔累计申购、定期 定额投资该份额的金额超过50000人民币元，本公司将部分或全部拒绝。该份额暂停上述大额业务期 间，其他业务仍照常办理。本基金汇添富纳斯达克生物科技ETF发起式联接（QDII）人民币A恢复大额 申购、大额定期定额 ...

Group 1 - Multiple public fund institutions have resumed normal and large-scale subscription for QDII funds since July, indicating a trend of "opening the door" for investors [1][2] - Specific funds such as Huazhong Fund's Huazhong France CAC40 ETF and Huazhong Nikkei 225 ETF have resumed subscriptions after being suspended since March [2] - Some institutions have increased the upper limit for large subscriptions, with Penghua Fund raising the limit for certain fund accounts from 50,000 RMB to 100,000 RMB and from 10,000 USD to 20,000 USD [2] Group 2 - The resumption of QDII funds is driven by two main factors: the approval of an additional 30.8 billion USD in QDII investment quotas and the unique cross-border investment advantages of QDII funds [3] - The number of QDII funds has nearly doubled from 161 to 317 over the past five years, with total assets growing from 115.5 billion RMB to 654.3 billion RMB, representing a 466% increase [4] - QDII funds play a crucial role in asset allocation, providing investors with diverse asset choices and optimizing risk-return characteristics through global market exposure [4] Group 3 - Investors are advised to consider factors such as currency fluctuations and geopolitical risks when investing in QDII funds, and to assess their risk tolerance accordingly [5] - QDII funds focused on the Hong Kong stock market have outperformed their peers this year, with specific funds achieving top net value growth rates [5] - The Hong Kong market is expected to continue expanding with more quality listings, driven by supportive policies [5]

Core Viewpoint - Several public fund institutions have resumed normal subscription operations for QDII products and increased the upper limit for large subscriptions, supported by a total investment quota of $30.8 billion issued by the State Administration of Foreign Exchange [1][3]. Group 1: QDII Product Resumption - Multiple QDII products have resumed normal subscription operations, with significant adjustments to large subscription limits. For instance, Hua Bao's Nasdaq Select Stock Fund raised its limit from 5,000 yuan to 20,000 yuan, while other funds also saw similar increases [2]. - Hua An Fund and Huitianfu Fund have also announced the resumption of subscription services for their respective QDII products, indicating a broader trend among public funds to enhance investment accessibility [2]. Group 2: New Investment Quotas - The State Administration of Foreign Exchange has granted a total of $30.8 billion in new investment quotas to several qualified QDII institutions, with notable approvals for Hua An Fund, Southern Fund, and Huaxia Fund among others [3][4]. - As of the end of June, the total approved quota for securities institutions reached $942.90 billion, reflecting an increase of over $20 billion from the end of May [3]. Group 3: Market Implications - The increase in QDII quotas is expected to meet investors' demand for diversified overseas asset allocation, facilitating cross-border investments and enhancing the integration of domestic capital markets with international markets [4]. - The trend of overseas diversification is becoming increasingly popular among investors, especially during periods of domestic market volatility, as it provides alternative sources of returns [5]. Group 4: Investment Opportunities - The chief investment officer of Hua Bao Fund noted that the first half of 2025 experienced a global asset rebalancing, with non-US equity funds seeing net inflows, suggesting a favorable environment for risk assets [6]. - Investment opportunities in the Hong Kong market are highlighted, with expectations of continued attractiveness due to the internationalization of the renminbi and the influx of capital [6].